High ROIC Stocks
LLY is currently part of our High ROIC Stocks screen, indicating it generates strong returns on invested capital.
ELI LILLY & CO (LLY) Stock Price & Overview
NYSE:LLY • US5324571083
Current stock price
935.58 USD
-18.94 (-1.98%)
At close:
935.98 USD
+0.4 (+0.04%)
After Hours:
The current stock price of LLY is 935.58 USD. Today LLY is down by -1.98%. In the past month the price decreased by -4.85%. In the past year, price increased by 26.74%.
LLY Key Statistics
52-Week Range623.78 - 1133.95
Current LLY stock price positioned within its 52-week range.
1-Month Range877.11 - 1012
Current LLY stock price positioned within its 1-month range.
- Market Cap
- 882.589B
- P/E
- 38.64
- Fwd P/E
- 26.76
- EPS (TTM)
- 24.21
- Dividend Yield
- 0.77%
LLY Stock Performance
Today
-1.98%
1 Week
+4.30%
1 Month
-4.85%
3 Months
-13.40%
Longer-term
6 Months +11.40%
1 Year +26.74%
2 Years +19.78%
3 Years +136.34%
5 Years +411.89%
10 Years +1,138.69%
LLY Stock Chart
LLY Stock Screens
LLY currently appears in the following ChartMill screener lists.
Fastest Growing Stocks
LLY is part of our fastest growing stocks screen, indicating it has high EPS and sales growth.
Revenue Growth Leaders
LLY is part of our revenue growth leaders stock screen, indicating it has strong recent and multi-year revenue growth.
LLY Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to LLY. When comparing the yearly performance of all stocks, LLY turns out to be only a medium performer in the overall market: it outperformed 51.45% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
LLY Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to LLY. While LLY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
LLY Earnings
On February 4, 2026 LLY reported an EPS of 7.54 and a revenue of 19.29B. The company beat EPS expectations (11.92% surprise) and beat revenue expectations (6.36% surprise).
Next Earnings DateApr 30, 2026
Last Earnings DateFeb 4, 2026
PeriodQ4 / 2025
EPS Reported$7.54
Revenue Reported19.292B
EPS Surprise 11.92%
Revenue Surprise 6.36%
LLY Forecast & Estimates
39 analysts have analysed LLY and the average price target is 1225.45 USD. This implies a price increase of 30.98% is expected in the next year compared to the current price of 935.58.
For the next year, analysts expect an EPS growth of 44.39% and a revenue growth 28.37% for LLY
Analysts
Analysts81.54
Price Target1225.45 (30.98%)
EPS Next Y44.39%
Revenue Next Year28.37%
LLY Groups
Sector & Classification
Sector
Health Care Sub-Industry
Pharmaceuticals LLY Financial Highlights
Over the last trailing twelve months LLY reported a non-GAAP Earnings per Share(EPS) of 24.21. The EPS increased by 86.23% compared to the year before.
Income Statements
Revenue(TTM)65.18B
Net Income(TTM)20.64B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 31.66% | ||
| ROA | 18.35% | ||
| ROE | 77.78% | ||
| Debt/Equity | 1.54 |
Chartmill High Growth Momentum
EPS Q2Q%41.73%
Sales Q2Q%42.56%
EPS 1Y (TTM)86.23%
Revenue 1Y (TTM)44.7%
LLY Ownership
Ownership
Inst Owners84.52%
Shares943.36M
Float940.96M
Ins Owners0.18%
Short Float %0.73%
Short Ratio2.15
LLY Latest News, Press Relases and Analysis
4 days ago - By: Chartmill
LLY Competitors/Peers
The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | 20.87 | 585.389B | ||
| MRK | MERCK & CO. INC. | 23.36 | 298.838B | ||
| PFE | PFIZER INC | 9.48 | 161.094B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.41 | 121.374B | ||
| ZTS | ZOETIS INC | 16.66 | 49.786B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.4 | 28.018B | ||
| VTRS | VIATRIS INC | 5.36 | 15.475B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.94 | 11.475B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.619B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.372B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.599B | ||
| CORT | CORCEPT THERAPEUTICS INC | 51.43 | 4.52B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LLY
Company Profile
The company is headquartered in Indianapolis, Indiana and currently employs 50,000 full-time employees.
Company Info
IPO: 1970-07-09
ELI LILLY & CO
Lilly Corporate Ctr, Drop Code 1094
Indianapolis INDIANA 46285 US
CEO: David A. Ricks
Employees: 50000
Phone: 13172762000
ELI LILLY & CO / LLY FAQ
Can you describe the business of ELI LILLY & CO?
The company is headquartered in Indianapolis, Indiana and currently employs 50,000 full-time employees.
What is the stock price of ELI LILLY & CO today?
The current stock price of LLY is 935.58 USD. The price decreased by -1.98% in the last trading session.
Does ELI LILLY & CO pay dividends?
ELI LILLY & CO (LLY) has a dividend yield of 0.77%. The yearly dividend amount is currently 5.69.
How is the ChartMill rating for ELI LILLY & CO?
LLY has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What do analysts say about ELI LILLY & CO (LLY) stock?
39 analysts have analysed LLY and the average price target is 1225.45 USD. This implies a price increase of 30.98% is expected in the next year compared to the current price of 935.58.
Is ELI LILLY & CO (LLY) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LLY.
Can you provide the market cap for ELI LILLY & CO?
ELI LILLY & CO (LLY) has a market capitalization of 882.59B USD. This makes LLY a Mega Cap stock.